Evaluate the PK, Safety, Tolerability of Ferric Maltol at 3 Dosage Levels in Paediatric Subjects With Iron Deficiency
Clinical trial NCT03181451 · COMPLETED
Trial details
- NCT number
- NCT03181451
- Sponsor
- Shield Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-14
- Primary completion
- 2018-03-28
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.